Navegando por Palavras-chave "Refluxo laringofaríngeo"

Agora exibindo 1 - 2 de 2
  • Imagem de Miniatura
    Item
    Acesso aberto (Open Access)
    Avaliação da disfagia e do refluxo laringofaringeo em pacientes com apnéia obstrutiva do Sono
    (Universidade Federal de São Paulo (UNIFESP), 2018-06-28) Caparroz, Fabio de Azevedo [UNIFESP]; Haddad, Fernanda Louise Martinho [UNIFESP]; http://lattes.cnpq.br/2110917250638917; http://lattes.cnpq.br/6982046861974842; Universidade Federal de São Paulo (UNIFESP)
    Objectives: to evaluate whether the presence of signs and symptons suggestive of laryngopharingeal reflux are associated with the presence of dysphagia in patients with moderate and severe obstructive sleep apnea (OSA), and also evaluate whether endoscopic signs of dysphagia could be reverted by treatment with CPAP in patients with OSA. Methods: 70 patients among 18 and 70 years old with moderate or severe OSA were included in the study. The following questionnaries were applied: RSI (Reflux Sympton Index) and Quality of Life in Swallowing Disorders (Swal-Qol). Functional Endoscopy Evaluation of Swallowing Safety (FEESS) and video-laryngoscopy, in order to obtain Reflux Finding Score (RFS), were also performed. The patients with diagnosis of dysphagia on FEESS were followed-up to 3 months, and then reavaluated according to the same protocol. Results: the prevalence of laryngopharingeal reflux on our sample was 59,7%, and the prevalence of dysphagia was 27,3%, inferior than previous studies. Association between laryngopharingeal reflux and dysphagia was found on 17,1% of the patients, with no statistical significance. Lower quality of life scores were observed in only one domain of Swal-Qol in patients with dysphagia and OSA. There was a significantly improvement of deglutition disorders on FEESS after treatment with CPAP (p=0,004), as well as quality of life measured by Swal-Qol (global score, p = 0,028), in patients with dysphagia and OSA, after 3 months. Conclusions: There was no association between laryngopharingeal reflux and dysphagia in patients with OSA on the present study. Prevalence of dysphagia, showed mostly by premature oral leakage, was 27,3% on our sample, inferior to previous studies. It seems to be a lower additional impact on quality of life, measured by Swal-Qol, in patients with dysphagia and OSA. Treatment with CPAP was capable of reverting endoscopic signs of dysphagia on FEESS in patients with OSA.
  • Imagem de Miniatura
    Item
    Acesso aberto (Open Access)
    Impacto adicional de práticas não farmacológicas associadas ao tratamento medicamentoso nos sintomas do refluxo laringofaríngeo
    (Universidade Federal de São Paulo (UNIFESP), 2018-10-25) Moreira, Marinalva Aparecida [UNIFESP]; Biase, Noemi Grigoletto De [UNIFESP]; http://lattes.cnpq.br/3156326658988323; http://lattes.cnpq.br/3886612683861842; Universidade Federal de São Paulo (UNIFESP)
    Gastroesophageal reflux (GER) is a spontaneous movement of the gastric contents of the stomach into the esophagus, considered physiological. When the reflux product reaches the supraesophageal regions - pharynx and larynx - symptoms of laryngopharyngeal reflux (LPR) occur, characterized by dysfunction in the upper esophageal sphincter (UES). The most frequent symptoms of LPR are: pharyngeal globus, throat clearing, halitosis, dysphonia, odynophagia, dysphagia, regurgitation, cough, among others; having as characteristic signs subglottic edema, ventricular obliteration, erythema/hyperemia, vocal fold edema, diffuse laryngeal edema, interaritenoid hypertrophy, granuloma/granulation tissue, thick endolaryngeal mucus, among others. LPR is a disease with a negative impact on quality of life. Objective: To evaluate the additional contribution of non-pharmacological measures simultaneous to drug treatment in the symptoms of laryngopharyngeal reflux. Method: This is a randomized clinical study, performed at the Unifesp - Escola Paulista de Medicina, in the Laryngology and Voice Ambulatory, which is part of the Department of Otorhinolaryngology and Head and Neck Surgery. The sample consisted of 32 patients, divided by lot in two groups, A and B, and both groups underwent pharmacological treatment. Only group A performed simultaneous treatment with the behavioral measures. The treatment lasted for 90 days, divided into three visits, the first one for the diagnosis through videolaryngoscopy and application of the scale of symptoms, the second to reinforce the adherence to the treatment, and the third to finish the study, with a new scale application of symptoms. For diagnosis of the patients, two otorhinolaryngologists, who filled out the Reflux Finding Score (RFS) scale, analyzed the videolaryngoscopy images. The reliability analysis of the total score of the RFS (signal scale) was done with the total sample, using the intraclass correlation coefficient (ICC). To assess the additional contribution of pharmacological measures concurrent to drug treatment in RLF symptoms, the groups A (medication + orientation) and B (medication) were compared in the initial moment in relation to age and signs and symptoms; after 15 days in relation to the adhesion and, after three months, in relation to the improvement of the symptoms. For all statistical tests used in these comparisons, the level of significance was set at 5%. Results:The sample consisted of 62% female, 69% workers, mean age 49.3 years (26 to 83 years). According to the scale of signs observed in videolaryngoscopy for LPR diagnosis, the value of the intraclass correlation coefficient referring to the concordance of the total Reflux Finding Score - RFS, in the study performed by two observers with 32 subjects were 0.560 (95% IC: 0.267 – 0.758), indicating moderate / satisfactory reliability. According to the assessment at baseline, the groups were similar in age; total score scale (mean=9.8 and standard deviation=2.57) and total symptom scale score (mean=15.1 and standard deviation=8.84). The RLF diagnosis was considered positive when the IHR criterion was> = 13 and or RFS > = 7, the symptoms presented approximately 18/32 (56.3%) and the signs were positive in 27/32 (84.4%). Patients in both groups were similar about adherence to treatment: 93.8% of patients took the medication regularly, 84.4% did not feel discomfort with medication and 81.3% stated that they were easily able to perform behavioral measures. In the whole sample there was an improvement in the intensity of the symptoms (total score), from the pre-post treatment moment in the whole sample (p=0.001). The reduction of the total score scale was statistically significant in Group A (p=0.031) and in Group B (p=0.008). When analyzing in which of the groups the patients improved, no statistically significant difference was found (p=0.659). Conclusion: There was similar improvement in symptoms in the two groups of patients, those receiving exclusive pharmacological treatment and those receiving concomitant non-pharmacological guidance, however, no additional impact of behavioral measures was observed in this group of patients with symptoms of laryngopharyngeal reflux.